Abstract
Rheumatoid factor (RF) is frequently tested in general practice where its utility as a diagnostic test for rheumatoid arthritis (RA) is not known. We undertook a retrospective cross-sectioal study to determine the utility and cost of RF in a primary care population. We compared RF with recorded clinical features based on the American College of Rheumatology (ACR) criteria as a diagnostic test for RA in 235 patients in general practice using receiver operating characteristic curves and calculated the cost of testing per case of RA. We analysed 36,191 RF requests made to one laboratory from 2003–2009 at a mean annual cost of £58,164 and the variation and annual cost of RF testing between 77 practices. The sensitivity and specificity of RF at the optimal cut-off value of 20 U/ml were 0.6 and 0.96 and that of two documented clinical ACR criteria were 0.9 and 0.92, respectively. No ACR criteria were documented in 150 (63.8 %) patients who had RF tested. The overall cost of RF testing per case of seropositive RA was £708.75. Of all RF requests, 66.6 % was made by GPs, 7.0 % by rheumatologists and 26.4 % by other hospital departments. The proportion of positive tests was 5.8 % in primary care and 17.7 % in rheumatology. The mean number of tests performed annually in primary care was 4.65 (SD 2.7) per 1,000 patients. RF is less sensitive for RA than clinical features in primary care and is frequently requested in cases without clinical evidence of the disease, adding to the overall cost.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Farragher TM, Lunt M, Fu B, Bunn D, Symmons DP (2010) Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis. Ann Rheum Dis 69(4):689–695
van der Linden MP, le Cessie S, Raza K, van der Woude D, Knevel R, Huizinga TW et al (2010) Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum 62(12):3537–3546
Thomas MJ, Adebajo A, Chapel HM, Webley M (1995) The use of rheumatoid factors in clinical practice. Postgrad Med J 71(841):674–677
Sinclair D, Hull RG (2003) Why do general practitioners request rheumatoid factor? A study of symptoms, requesting patterns and patient outcome. Ann Clin Biochem 40(Pt 2):131–137
Sokka T, Pincus T (2009) Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35 %–45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States. J Rheumatol 36(7):1387–1390
Bukhari M, Lunt M, Harrison BJ, Scott DGI, Symmons DPM, Silman AJ (2002) Erosions in inflammatory polyarthritis are symmetrical regardless of rheumatoid factor status: results from a primary care-based inception cohort of patients. Rheumatology 41(3):246–252
van Schaardenburg D, Lagaay AM, Otten HG, Breedveld FC (1993) The relation between class-specific serum rheumatoid factors and age in the general population. Br J Rheumatol 32(7):546–549
Husby G, Gran JT, Johannessen A (1988) Epidemiological and genetic aspects of IgM rheumatoid factors. Scand J Rheumatol Suppl 75:213–218
Nielson SF, Bojesen SE, Schnohr P, Nordestgaard BG (2012) Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ 345:e5244. doi:10.1136/bmj.e5244
Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S et al (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146(11):797–808
National Institute for Health and Clinical Excellence (2009) Rheumatoid arthritis: the management of rheumatoid arthritis in adults. National Institute for Health and Clinical. Excellence - Clinical Guidelines, London
Luqmani R, Hennell S, Estrach C, Basher D, Birrell F, Bosworth A et al (2009) British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). Rheumatology (Oxford) 48(4):436–439
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569–2581
Xu D, Groom C (2009) Economic models of identification and treatment of early rheumatoid arthritis. National Audit Office, London
van der Weijden T, van Bokhoven MA, Dinant GJ, van Hasselt CM, Grol RP (2002) Understanding laboratory testing in diagnostic uncertainty: a qualitative study in general practice. Br J Gen Pract 52(485):974–980
Gran JT, Nordvag BY (2000) Referrals from general practice to an outpatient rheumatology clinic: disease spectrum and analysis of referral letters. Clin Rheumatol 19(6):450–454
Suarez-Almazor ME, Gonzalez-Lopez L, Gamez-Nava JI, Belseck E, Kendall CJ, Davis P (1998) Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians. J Rheumatol 25(10):1980–1985
Spector TD, Hart DJ, Powell RJ (1993) Prevalence of rheumatoid arthritis and rheumatoid factor in women: evidence for a secular decline. Ann Rheum Dis 52(4):254–257
Acknowledgments
The authors would like to thank Dr Richard Silvester and Dr Peter Burke for providing access to data on their patients, and Carina Dunford and Jackie Masters for providing primary care demographic data.
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miller, A., Mahtani, K.R., Waterfield, M.A. et al. Is rheumatoid factor useful in primary care? A retrospective cross-sectional study. Clin Rheumatol 32, 1089–1093 (2013). https://doi.org/10.1007/s10067-013-2236-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-013-2236-0